文献速递神经肌肉病

抗肌萎缩相关糖蛋白病中的疾病相关肌肉无力

Illness-associated muscle weakness in dystroglycanopathies.
PubMed 文献 · Neurology · 2017-11-03

本研究基于DG自然历史研究及电子调查,描述抗肌萎缩相关糖蛋白病(DG)患者急性疾病相关无力(AIAW)现象。DG患者AIAW报告率23%,显著高于Duchenne-Becker肌营养不良(DBMD)的4%(OR 7.35,95%CI 1.55-34.77,p=0.005)。AIAW多发生于7岁以下儿童,常继发于呼吸道感染,部分先于肌营养不良诊断。

要点

  • DG患者可出现发热性疾病相关的急性短暂性无力,发生率约23%。
  • AIAW在DBMD中罕见(4%),提示DG特异性现象。
  • AIAW多见于7岁以下儿童,常先于肌营养不良诊断。

核心结论

  • DG患者跨基因型可发生发热性疾病相关的急性短暂性无力,该现象在DBMD中罕见。

研究设计与样本

  • 基于DG自然历史研究(NCT00313677)的队列,辅以电子调查收集DG和DBMD患者信息。
  • 调查完成者包括52例(56.6%)DG患者和51例(27.3%)DBMD患者。

主要发现

  • AIAW在DG中报告12例(23%),在DBMD中报告2例(4%)。
  • DG与DBMD的AIAW比值比为7.35(95%CI 1.55-34.77,p=0.005)。
  • 结合病史或调查,共21例DG患者(涉及FKRP、FKTN、POMT1、POMT2或POMGNT1突变)报告AIAW。
  • AIAW事件通常发生于7岁以下儿童,前驱疾病常包括呼吸道症状。
  • 10例(47.6%)DG患者的AIAW先于肌营养不良诊断。

临床怎么用

  • 对DG患者,尤其7岁以下儿童,发热性疾病期间需警惕急性短暂性无力。
  • AIAW可先于肌营养不良诊断出现,提示对不明原因急性无力儿童应评估DG可能。

局限性

  • AIAW的生理基础未知。
  • 调查应答率在DG为56.6%、DBMD为27.3%,可能存在应答偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To describe the phenomenon of acute illness-associated weakness (AIAW) in patients with dystroglycanopathy (DG), determine the frequency of this phenomenon in DGs, and compare it to the frequency in Duchenne-Becker muscular dystrophy (DBMD). METHODS: Patients enrolled in a DG natural history study provided medical history, including major illnesses or hospitalizations, at enrollment and annually. We noted a recurring syndrome of profound transient weakness in the setting of febrile illness. To determine the frequency of this phenomenon in the DG cohort and compare it to a cohort with another membrane-related muscular dystrophy, DBMD, we surveyed patients (e-survey tool), collecting demographics and information about episodes of sudden progression of weakness and events surrounding the episodes. RESULTS: Surveys were completed by 52 (56.6%) patients with DG and 51 (27.3%) patients with DBMD. AIAW was reported in 12 (23%) patients with DG and 2 (4%) patients with DBMD (odds ratio 7.35; 95% confidence interval 1.55, 34.77; p = 0.005). Altogether (history or survey), 21 patients with DG, with mutations in FKRP, FKTN, POMT1, POMT2, or POMGNT1, reported AIAW. These events typically occurred in children <7 years old, and the preceding illness usually included respiratory symptoms. In 10 (47.6%) patients with DG, AIAW preceded the diagnosis of muscular dystrophy. CONCLUSIONS: People with DG, across genotypes, can experience acute, transient weakness associated with a febrile illness, a phenomenon that rarely occurs in DBMD. The physiologic basis of this phenomenon is unknown. CLINICALTRIALSGOV IDENTIFIER: NCT00313677.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Carlson CR, McGaughey SD, Eskuri JM, et al. Illness-associated muscle weakness in dystroglycanopathies. Neurology. 2017. PMID: 29101272. doi:10.1212/WNL.0000000000004720

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。